Midazolam Nasal Spray
Abstract
Midazolam is a short acting benzodiazepine available as Midazolam hydrochloride which is water soluble. It primarily acts as a CNS depressant enhancing the actions of inhibitory neurotransmitter GABA.
Midazolam nasal spray is a new special formulation which is specifically indicated for intranasal administration of Midazolam during emergency situations like acute management of ongoing seizures in the pre hospital and intrahospital settings. Intranasal Midazolam may be prescribed for a child with epilepsy or febrile seizures who often has seizures lasting longer than five minutes or has a pattern of seizures that recur close together. It is also being used as a sedative for short outpatient surgical procedures.
The clinical manifestations of Midazolam toxicity are mostly due to CNS depression and include somnolence, confusion, ataxia and coma.
When publishing with Kerala Medicial Journal (KMJ), authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Work includes the material submitted for publication and any other related material submitted to KMJ. In the event that KMJ does not publish said work, the author(s) will be so notified and all rights assigned hereunder will revert to the author(s).
The assignment of rights to KMJ includes but is not expressly limited to rights to edit, publish, reproduce, distribute copies, include in indexes or search databases in print, electronic, or other media, whether or not in use at the time of execution of this agreement.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
The author(s) hereby represents and warrants that they are sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, that the work is original, and does not infringe upon any copyright, propriety, or personal right of any third party, and that no part of it nor any work based on substantially similar data has been submitted to another publication.
